| 000 | 01890 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517234611.0 | ||
| 264 | 0 | _c20190415 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1525-5069 | ||
| 024 | 7 |
_a10.1016/j.yebeh.2018.08.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIbrahim, Fatma A S | |
| 245 | 0 | 0 |
_aThe differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial. _h[electronic resource] |
| 260 |
_bEpilepsy & behavior : E&B _c10 2018 |
||
| 300 |
_a32-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 |
_aDocosahexaenoic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Resistant Epilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aEicosapentaenoic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGhebremeskel, Kebreab | |
| 700 | 1 | _aAbdel-Rahman, Manar E | |
| 700 | 1 | _aAhmed, Amar A M | |
| 700 | 1 | _aMohmed, Inaam M | |
| 700 | 1 | _aOsman, Ghada | |
| 700 | 1 | _aElseed, Maha | |
| 700 | 1 | _aHamed, Ahlam | |
| 700 | 1 | _aRabinowicz, Adrian L | |
| 700 | 1 | _aSalih, Mohamed A M | |
| 700 | 1 | _aElbashir, Mustafa I | |
| 700 | 1 | _aDaak, Ahmed A | |
| 773 | 0 |
_tEpilepsy & behavior : E&B _gvol. 87 _gp. 32-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yebeh.2018.08.016 _zAvailable from publisher's website |
| 999 |
_c28791282 _d28791282 |
||